Patents
We pride ourselves on running a patient-focused innovative program dedicated to advanced wound care and bleeding control. Our team is always exploring new opportunities and technologies to develop cutting-edge products and design new innovative solutions to improve patient care.
Are you interested in licensing Tricol Biomedical technology? Please contact us using the form on this page. Depending on the technology of interest, we can accommodate a range of licensing alternatives, including exclusive, non-exclusive, field of use, and other limited licenses.
HemCon® Bandage Family
(HemCon® Bandage PRO, HemCon Patch® PRO, ChitoDot®)
United States
7482503
United States
7820872
United States
8269058
United States
8313474
United States
8668924
Australia
2002312493
Canada
2450668
European Patent
1401352
European Patent
1704225
France
EP1401352
France
EP1704225
Germany
1401352
Germany
1704225
Israel
159339
Israel
184044
Japan
4332030
Japan
4812630
Japan
4854084
Korea
953465
Korea
953466
Korea
10-1105081
Korea
10-1148248
Netherlands
1401352
United Kingdom
EP1401352
United Kingdom
EP1704225
HemCon® Advanced Chitosan Uses
Biocompatible and bioabsorbable derivatized chitosan compositions
e.g., U.S. Patent Nos. 9,925,310, 9,547,011, and patents pending.
Percutaneous vascular injury treatment systems and methods
e.g., PCT/US2016/012732, published as WO/2016/112342, and patents pending.
Bioadhesive chitosan gel for controlling bleeding and for promoting healing with scar reduction without obscuring or interfering with access to a surgical field e.g., PCT/US2016/026939, published as WO/2016/164903, and patents pending.
Chitosan superfine fiber systems e.g., PCT/US17/17685, published as WO 2017/139775, and patents pending.
Interested in licensing Tricol Biomedical technology?